Apigenin: A Therapeutic Agent for Treatment of Skin Inflammatory Diseases and Cancer.

Ji Hye Yoon, Mi-Yeon Kim, Jae Youl Cho

Journal: International journal of molecular sciences 2023;24(2):1498

PMID: 36675015

Abstract

The skin is the main barrier between the body and the environment, protecting it from external oxidative stress induced by ultraviolet rays. It also prevents the entrance of infectious agents such as viruses, external antigens, allergens, and bacteria into our bodies. An overreaction to these agents causes severe skin diseases, including atopic dermatitis, pruritus, psoriasis, skin cancer, and vitiligo. Members of the flavonoid family include apigenin, quercetin, luteolin, and kaempferol. Of these, apigenin has been used as a dietary supplement due to its various biological activities and has been shown to reduce skin inflammation by downregulating various inflammatory markers and molecular targets. In this review, we deal with current knowledge about inflammatory reactions in the skin and the molecular mechanisms by which apigenin reduces skin inflammation.

Address: Department of Biocosmetics, Sungkyunkwan University, Suwon 16419, Republic of Korea.; School of Systems Biomedical Science, Soongsil University, Seoul 06978, Republic of Korea.; Department of Integrative Biotechnology, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.